Melphalan
CAS No. 148-82-3
Melphalan ( L-PAM )
Catalog No. M12056 CAS No. 148-82-3
A chemotherapy agent that acts through alkylation of the DNA nucleotide guanine, and causes linkages between strands of DNA; inhibits DNA synthesis and RNA synthesis in both dividing and non-dividing tumor cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMelphalan
-
NoteResearch use only, not for human use.
-
Brief DescriptionA chemotherapy agent that acts through alkylation of the DNA nucleotide guanine, and causes linkages between strands of DNA; inhibits DNA synthesis and RNA synthesis in both dividing and non-dividing tumor cells.
-
DescriptionA chemotherapy agent that acts through alkylation of the DNA nucleotide guanine, and causes linkages between strands of DNA; inhibits DNA synthesis and RNA synthesis in both dividing and non-dividing tumor cells. Chemotherapeutic Agents Approved
-
SynonymsL-PAM
-
PathwayCell Cycle/DNA Damage
-
TargetDNA Alkylator
-
RecptorDNA Alkylator
-
Research AreaCancer
-
IndicationChemotherapeutic
Chemical Information
-
CAS Number148-82-3
-
Formula Weight305.20
-
Molecular FormulaC13H18Cl2N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: < 9.2 mg/mL
-
SMILESN[C@@H](CC1=CC=C(N(CCCl)CCCl)C=C1)C(O)=O
-
Chemical NameL-Phenylalanine, 4-[bis(2-chloroethyl)amino]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dudek-Peri AM, et al. Cancer Res. 2015 Apr 15;75(8):1603-14.
2. Keane MM, et al. Cancer Res. 1999 Feb 1;59(3):734-41.
2. Keane MM, et al. Cancer Res. 1999 Feb 1;59(3):734-41.
molnova catalog
related products
-
Quinacrine dihydroch...
An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years.
-
Thio-TEPA
An alkylating agent used to treat cancer that has been previously used in the palliation of a wide variety of neoplastic diseases.
-
Melflufen
Melflufen is a novel dipeptide and alkylating prodrug of melphalan, inhibits angiogenesis in vitro and in vivo; shows cytotoxic activity against lymphoma cell lines with IC50 of 0.011-0.92 uM, also shows significantly lower IC50 than melphalan in multiple myeloma cells.